Source: International Congress 2015 – Emerging strategies for airway disease treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Abeer Kassem (Alexandria, Egypt), Dalal El Giziry, Nermin Zakaria, Abeer Kassem, Mona Abdellatif. LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity. Eur Respir J 2015; 46: Suppl. 59, 4373

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Serum periostin as a valuable biomarker of comorbid chronic rhinosinusitis in patients with asthma Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 TSLP as biomarker in asthma patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 LATE-BREAKING ABSTRACT: Multinational, database cohort study to assess severe exacerbation rate in asthma Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Defining asthma COPD overlap syndrome (ACOS): A population based study Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 LATE-BREAKING ABSTRACT: Exploratory study of clinical phenotypes of airways disease with wheezing by cluster analysis Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 LATE-BREAKING ABSTRACT: Transcriptomic fingerprinting in severe adult-onset asthma shows type2-high and inflammatory-cell gene signatures in the U-BIOPRED cohort Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 Immunology indices in severe bronchial asthma with different levels of disease control in children Source: Annual Congress 2013 –Asthma Year: 2013 LATE-BREAKING ABSTRACT: Prevalence of metabolic syndrome in COPD and its association with severity of disease Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Periostin and TSLP: New markers useful in diagnosis of obstructive lung disease Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 LATE-BREAKING ABSTRACT: The analysis of the severe asthma prevalence rate in China Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016 Usefulness of periostin as a biomarker of pediatric asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014